The leading aim was to identify appropriate analytical targets by analyzing human hepatocyte incubation samples with high-resolution mass spectrometry (HRMS) and to verify the effects in genuine urine specimens and to determine AB-FUBINACA's metabolic stability in human liver microsomes and when